AstraZeneca Pharma India
BSE 506820
2 stories, newest first.
- New Mumbai corporate office inaugurated, described as the next phase of growth
- NSE Sustainability assigns ESG rating of 73 to AstraZeneca Pharma India for FY2025-26
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.